Johnson & Johnson (NYSE:JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental Biologics License Application (sBLA) for subcutaneous ...
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the second quarter ended June 30, 2026.
Second Quarter Results Total revenues of $38.4 million, a 5% year-over-year improvementNet loss of $(4.6) million and loss per share of $(1.71), ...
Ranpak Holdings Corp. (NYSE: PACK) (“Ranpak” or “the Company”), a leading provider of environmentally sustainable, systems-based, product protection and end-of-line automation solutions for e-commerce ...
Dosing underway in Phase 2a multidose portion of the INLIGHTTM trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with obesity (BMI: 35-50 ...
Patrick Industries, Inc. ("Patrick" or the "Company"), a leading component solutions provider for the Outdoor Enthusiast and Housing markets, today reported financial results for the second quarter ...
Hello everybody, and welcome to the Q2 2026 Teva Pharmaceutical Industries Earnings Conference Call. My name is Elliot. I'll be coordinating your call today. [Operator Instructions] I would now like ...
Q2 2026 Earnings Call July 29, 2026 10:00 AM EDTCompany ParticipantsJulie Francis - CEO, President & DirectorBrandon Gall ...
Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results